World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
77
Citations
26323
World Ranking
1801
National Ranking
71

Anthony D. Kelleher publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Anthony D. Kelleher sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 379 publications — 78th percentile

78% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Anthony D. Kelleher D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Anthony D. Kelleher sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 77 D-Index — 64th percentile

64% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Anthony D. Kelleher is affiliated with the University of New South Wales in Australia. Their research primarily spans the fields of Medicine and Immunology and Microbiology, with a significant focus on subfields such as Infectious Diseases, Immunology, Virology, Neurology, and Molecular Biology.

The scientist's recent papers include notable publications in various high-impact journals. Examples of their work are:

  • Immunological dysfunction persists for 8 months following initial mild-to-moderate SARS-CoV-2 infection, 2022, Nature Immunology
  • SARS-CoV-2 Omicron BA.5: Evolving tropism and evasion of potent humoral responses and resistance to clinical immunotherapeutics relative to viral variants of concern, 2022, EBioMedicine
  • SARS-CoV-2 neutralizing antibodies: Longevity, breadth, and evasion by emerging viral variants, 2021, PLoS Medicine
  • Lymphoma Driver Mutations in the Pathogenic Evolution of an Iconic Human Autoantibody, 2020, Cell
  • Global and regional epidemiology of HIV-1 recombinants in 1990-2015: a systematic review and global survey, 2020, The Lancet HIV

Frequent collaborators include Stuart Turville, Gail Matthews, Anupriya Aggarwal, William D. Rawlinson, and C. Mee Ling Munier.

Publishing venues frequently featuring their work include bioRxiv (Cold Spring Harbor Laboratory), SSRN Electronic Journal, International Journal of Molecular Sciences, EBioMedicine, and Viruses.

Their main research topics cover several areas such as:

  • SARS-CoV-2 and COVID-19 Research
  • HIV Research and Treatment
  • COVID-19 Clinical Research Studies
  • Long-Term Effects of COVID-19
  • HIV/AIDS Research and Interventions
  • T-cell and B-cell Immunology
  • Immune Cell Function and Interaction

Best Publications

  • Circulating microRNAs in sera correlate with soluble biomarkers of immune activation but do not predict mortality in ART treated individuals with HIV-1 infection : a case control study

    Daniel D. Murray;Kazuo Suzuki;Matthew Law;Jonel Trebicka

  • Expression of interleukin (IL)-2 and IL-7 receptors discriminates between human regulatory and activated T cells

    Nabila Seddiki;Nabila Seddiki;Brigitte Santner-Nanan;Jeff Martinson;John Zaunders

  • Upregulation of CTLA-4 by HIV-specific CD4+ T cells correlates with disease progression and defines a reversible immune dysfunction.

    Daniel E Kaufmann;Daniel G Kavanagh;Florencia Pereyra;Florencia Pereyra;John J Zaunders

  • Characterization of CD4(+) CTLs ex vivo.

    Victor Appay;John J. Zaunders;Laura Papagno;Julian Sutton

  • Clustered Mutations in HIV-1 Gag Are Consistently Required for Escape from Hla-B27–Restricted Cytotoxic T Lymphocyte Responses

    Anthony D. Kelleher;Chad Long;Edward C Holmes;Rachel L. Allen

  • Viral suppression and HIV transmission in serodiscordant male couples: an international, prospective, observational, cohort study

    Benjamin R Bavinton;Angie N Pinto;Nittaya Phanuphak;Beatriz Grinsztejn

  • Early highly active antiretroviral therapy for acute HIV-1 infection preserves immune function of CD8+ and CD4+ T lymphocytes

    Annette Oxenius;David A. Price;Philippa J. Easterbrook;Christopher A. O'Callaghan

  • Dolutegravir plus lamivudine versus dolutegravir plus tenofovir disoproxil fumarate and emtricitabine in antiretroviral-naive adults with HIV-1 infection (GEMINI-1 and GEMINI-2): week 48 results from two multicentre, double-blind, randomised, non-inferiority, phase 3 trials

    Unknown

  • Escape from the dominant HLA-B27-restricted cytotoxic T-lymphocyte response in Gag is associated with a dramatic reduction in human immunodeficiency virus type 1 replication.

    Arne Schneidewind;Mark A. Brockman;Mark A. Brockman;Ruifeng Yang;Rahma I. Adam

  • Alterations in the Immune Response of Human Immunodeficiency Virus (HIV)-Infected Subjects Treated with an HIV-Specific Protease Inhibitor, Ritonavir

    A. D. Kelleher;A. Carr;J. Zaunders;D. A. Cooper

  • HIV-1 DNA predicts disease progression and post-treatment virological control

    James P Williams;Jacob Hurst;Jacob Hurst;Wolfgang Stöhr;Nicola Robinson;Nicola Robinson

  • Short-course antiretroviral therapy in primary HIV infection.

    S Fidler;K Porter;F Ewings

  • Human Immunodeficiency Virus Type 1-Specific CD8+ T-Cell Responses during Primary Infection Are Major Determinants of the Viral Set Point and Loss of CD4+ T Cells

    Hendrik Streeck;Jonathan S. Jolin;Ying Qi;Bader Yassine-Diab

  • Antiretroviral therapy with the integrase inhibitor raltegravir alters decay kinetics of HIV, significantly reducing the second phase

    John M Murray;Sean Emery;Anthony D Kelleher;Matthew Law

  • Identification of circulating antigen-specific CD4+ T lymphocytes with a CCR5+, cytotoxic phenotype in an HIV-1 long-term nonprogressor and in CMV infection.

    John J. Zaunders;Wayne B. Dyer;Bin Wang;Mee Ling Munier

  • In Vivo, Nucleoside Reverse-Transcriptase Inhibitors Alter Expression of Both Mitochondrial and Lipid Metabolism Genes in the Absence of Depletion of Mitochondrial DNA

    Patrick W. G. Mallon;Patrick Unemori;Rebecca Sedwell;Adrienne Morey

  • Oligoclonal Expansions of CD8+ T Cells in Chronic HIV Infection Are Antigen Specific

    Jamie D.K. Wilson;Graham S. Ogg;Rachel L. Allen;Philip J.R. Goulder

  • Marked Epitope- and Allele-Specific Differences in Rates of Mutation in Human Immunodeficiency Type 1 (HIV-1) Gag, Pol, and Nef Cytotoxic T-Lymphocyte Epitopes in Acute/Early HIV-1 Infection

    Zabrina L. Brumme;Chanson J. Brumme;Jonathan Carlson;Jonathan Carlson;Hendrik Streeck

  • Rapid Reversion of Sequence Polymorphisms Dominates Early Human Immunodeficiency Virus Type 1 Evolution

    Bin Li;Adrianne D. Gladden;Marcus Altfeld;John M. Kaldor

  • High Levels of Human Antigen-Specific CD4+ T Cells in Peripheral Blood Revealed by Stimulated Coexpression of CD25 and CD134 (OX40)

    John J. Zaunders;Mee Ling Munier;Nabila Seddiki;Sarah Pett

  • Cytotoxic CD4 T Cells-Friend or Foe during Viral Infection?

    Jennifer A. Juno;David van Bockel;Stephen J. Kent;Stephen J. Kent;Anthony D. Kelleher;Anthony D. Kelleher

  • HIV disease progression despite suppression of viral replication is associated with exhaustion of lymphopoiesis

    Delphine Sauce;Martin Larsen;Solène Fastenackels;Michèle Pauchard

  • Recognition of a Defined Region within p24 Gag by CD8+ T Cells during Primary Human Immunodeficiency Virus Type 1 Infection in Individuals Expressing Protective HLA Class I Alleles

    Hendrik Streeck;Mathias Lichterfeld;Galit Alter;Angela Meier

  • Immunological dysfunction persists for 8 months following initial mild-moderate SARS-CoV-2 infection

    Chansavath Phetsouphanh;David Darley;Anette Howe;C. Mee Ling Munier

Frequent Co-Authors

David A. Cooper
David A. Cooper University of New South Wales
John Zaunders
John Zaunders Ascension Health
Stephen J. Kent
Stephen J. Kent University of Melbourne
Sean Emery
Sean Emery University of New South Wales
Kazuo Suzuki
Kazuo Suzuki Teikyo University
Bruce D. Walker
Bruce D. Walker Harvard University
Andrew Carr
Andrew Carr University of Oxford
Janaki Amin
Janaki Amin Macquarie University
Matthew Law
Matthew Law University of New South Wales
Sharon R. Lewin
Sharon R. Lewin University of Melbourne

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in Immunology, pursuing related online degrees can open doors to diverse healthcare careers. Nursing pathways, especially those focusing on specialties like Psychiatric Mental Health Nurse Practitioner (PMHNP), offer rewarding options. Many programs balance flexibility with rigorous clinical training, making it useful to explore the what is the easiest np program to find the right fit for your schedule and learning style.

Specialized tracks like the best online psychiatric mental health nurse practitioner programs ensure strong clinical placements, which are essential for hands-on experience and career readiness. Cost is often a concern, so comparing the cheapest online pmhnp certificate programs can make advanced education more accessible without compromising quality.

After obtaining degrees such as a DNP (Doctor of Nursing Practice), graduates can expect competitive salary prospects. Insights into how much do dnps make help students assess financial outcomes by location, informing their career planning post-graduation.

By aligning your Immunology education with these related fields and career resources, you can better navigate educational choices and professional opportunities in healthcare.

Best Scientists Citing Anthony D. Kelleher

Trending Scientists

Recently Published Articles